This finding assumes particular interest in IGF2-driven cancer in light of the mechanistic demonstration of the dimeric requirement of C/EBPs towards gene target transcriptional activation, similarly to other bZIP family of DNA binding proteins (reviewed in [67]). The gene discussed is IGF2; the disease is cancer.